Matching slides 110,471
Current window 86,281-86,310
Pages 3,683
Rows per page 30
Component: Listclear collectionreset all

Component

86,281-86,310 of 110,471

filter-aware
07
Includes a boxed warning disclaimer at the bottom.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
08
The chart shows a steady upward trend in total prescriptions (TRx) over 61 weeks, with a notable dip around week 58.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
12
Alkermes | Investor Presentation Deck | 28 slidesAlkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
14
The slide uses a medical illustration of the brain to show neurotransmitter pathways.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · ActionLoop · Why Now1 hit
15
Includes a molecular structure visualization of the Orexin 2 receptor.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · ActionLoop · Why Now1 hit
23
The slide uses a 2x2 matrix-like layout to categorize studies by 'Potential Registration Enabling Studies' and 'Alternative Dosing Studies'.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · Action1 hit
26
The chart tracks revenue for VIVITROL, ARISTADA, VUMERITY, and LYBALVI.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · Action1 hit
27
Alkermes | Investor Presentation Deck | 28 slidesAlkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · Action1 hit
05
The slide uses a circular graphic featuring patient photos to emphasize the human-centric approach.argenx SE | Investor Conference Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · What IsLoop · Golden Circle1 hit
09
Includes a 3-step mechanism of action diagram.argenx SE | Investor Conference Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · What Could Be1 hit
11
The slide uses a hub-and-spoke style diagram to organize strategic pillars.argenx SE | Investor Conference Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · What Could Be1 hit
15
The slide highlights the mechanism of action (pH/Ca2+ switch, no effector function, optimal recycling) and the clinical pipeline status for MMN, delayed graft function, and dermatomyositis.argenx SE | Investor Conference Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · New BlissLoop · Before After1 hit
04
Slide 4 of a presentation, likely AstraZeneca.AstraZeneca | Investor Conference Presentation Deck | 18 slides · AstraZeneca
Conference presentation Investor relations Beat · Key MessagesLoop · Golden Circle1 hit
06
Uses a 2x2 grid layout to categorize capital allocation strategies.AstraZeneca | Investor Conference Presentation Deck | 18 slides · AstraZeneca
Conference presentation Investor relations Beat · Key MessagesLoop · Golden Circle1 hit
07
The slide uses a 'Growth Through Innovation' framework to categorize R&D focus areas.AstraZeneca | Investor Conference Presentation Deck | 18 slides · AstraZeneca
Conference presentation Investor relations Beat · KPI OverviewLoop · Golden Circle1 hit
10
Includes clinical trial data visualization and deal structure details.AstraZeneca | Investor Conference Presentation Deck | 18 slides · AstraZeneca
Conference presentation Investor relations Beat · Thesis HeadlineLoop · Golden Circle1 hit
14
The slide uses a numbered list to outline strategic pillars leading to a specific financial outcome.AstraZeneca | Investor Conference Presentation Deck | 18 slides · AstraZeneca
Conference presentation Investor relations Loop · Golden Circle1 hit
03
ATAI | Investor Presentation Deck | 33 slidesATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
06
The slide uses a timeline framework to communicate both past achievements and future R&D milestones.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Beat · Roadmap1 hit
08
Uses a vertical timeline-style list to present the 'Huge Need for Development' metrics.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Beat · Problem1 hit
10
The slide uses a vertical process flow to demonstrate clinical progression and de-risking.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Beat · Traction1 hit
15
The slide uses a split-layout: left side defines the disease and market size, right side outlines the clinical 'urgent need' for innovation.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
16
The slide uses a line chart to demonstrate the efficacy of different dosages of COMP360 over 12 weeks.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
18
The slide uses a split layout: a left-hand sidebar for product summary and a right-hand side for clinical data visualization.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
21
The slide uses a combination of a disease overview, market sizing metrics, and a 'massive unaddressed need' framework to justify the problem.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
23
Includes detailed TEAE (Treatment-emergent Adverse Event) breakdown by dose cohort.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
25
The chart displays pharmacodynamic data with error bars and significance markers (asterisks).ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
32
The slide uses a structured card-based layout to present four distinct business units.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
03
The slide uses a three-column layout to define the business model and provides quantitative evidence for each pillar at the bottom.Babylon | Investor Conference Presentation Deck | 19 slides · Babylon
Conference presentation Investor relations Beat · Setup1 hit
07
The funnel represents a care delivery hierarchy. The right side shows a visual correlation between care level, cost ($), and population size (Millions).Babylon | Investor Conference Presentation Deck | 19 slides · Babylon
Conference presentation Investor relations Beat · EvidenceLoop · Quick Win Big Bet1 hit